Rafi Ahmed

USPTO Granted Patents = 24 (Patent Applications = 13)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 15)

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 361(Granted Patents)

Company Filing History:

Dana-farber-cancer Institute Inc.

The Brigham and Women's Hospital, Inc.

patents

5. 3 out of 915

University of Chicago

patents

6. 2 out of 1,186

The Scripps Research Institute

patents

7. 2 out of 260

St. Jude Children's Research Hospital

Oklahoma Medical Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391746 - HPV proteins, antibodies, and uses in managing abnormal epithelial cell growth (2025-08-19),

2. 12329992 - Ebola virus antibodies and binding agents derived therefrom (2025-06-17),

3. 12161671 - Immune cells with DNMT3A gene modifications and methods related thereto (2024-12-10),

4. 11713349 - Ebola virus antibodies and binding agents derived therefrom (2023-08-01),

5. 11359013 - Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway (2022-06-14),

6. 11261251 - Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor (2022-03-01),

7. 11147870 - Specific binding agents to varicella-zoster virus and uses related thereto (2021-10-19),

8. 11124569 - Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors (2021-09-21),

9. 11020430 - Immune cells with DNMT3A gene modifications and methods related thereto (2021-06-01),

10. 10370448 - Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor (2019-08-06),

11. 10370446 - Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway (2019-08-06),

12. 10208107 - Antibodies directed against influenza (2019-02-19),

13. 10011656 - Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor (2018-07-03),

14. 9598491 - Methods for the treatment of infections and tumors (2017-03-21),

15. 9469685 - Antibodies directed against influenza (2016-10-18),

Title: The Innovative Journey of Inventor Rafi Ahmed

Introduction: Rafi Ahmed, a pioneering inventor based in Atlanta, GA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: Rafi Ahmed holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With over two decades of experience in the industry, Rafi Ahmed has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various sectors.

Collaborations: Throughout his career, Rafi Ahmed has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and knowledge sharing that has led to the development of cutting-edge technologies.

Conclusion: Inventor Rafi Ahmed's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs worldwide.

This text is generated by artificial intelligence and may not be accurate.